Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers. (NCT07665268)

🧪 Interventions in This Study

• Activate™ Matrix + SOC (OTHER)
• AmnioDefend™ FT Matrix + SOC (OTHER)
• Palisade™ DM Matrix + SOC (OTHER)
• Sentry™ SL Matrix + SOC (OTHER)
• Shelter™ DM Matrix + SOC (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Amber Stormer — North Royalton, Ohio

📞 Contact the Study Coordinator

Phone: (833) 865-6300

Email: info@serenagroups.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Skin Ulcer

• Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer — St John's,

Explore by condition: All Skin Ulcer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.